The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.
SingleArmMRCT provides functions to calculate and visualise the Regional Consistency Probability (RCP) for single-arm multi-regional clinical trials (MRCTs) using the Effect Retention Approach (ERA).
The package addresses a critical methodological gap: current Japanese MHLW Method 1 and Method 2 consistency criteria were originally developed for two-arm trials, yet single-arm trials increasingly form the basis of regulatory submissions, particularly in oncology. This package extends classical approaches to the single-arm setting across six endpoint types.
| Endpoint type | Calculation function | Plot function |
|---|---|---|
| Continuous | rcp1armContinuous() |
plot_rcp1armContinuous() |
| Binary | rcp1armBinary() |
plot_rcp1armBinary() |
| Count (negative binomial) | rcp1armCount() |
plot_rcp1armCount() |
| Time-to-event (hazard ratio) | rcp1armHazardRatio() |
plot_rcp1armHazardRatio() |
| Milestone survival | rcp1armMilestoneSurvival() |
plot_rcp1armMilestoneSurvival() |
| Restricted mean survival time (RMST) | rcp1armRMST() |
plot_rcp1armRMST() |
Each function supports two approaches:
"formula": Closed-form or
semi-analytical solution based on normal approximation."simulation": Monte Carlo
simulation.This package is not yet on CRAN. Install from source:
# Install devtools if not already installed
install.packages("devtools")
# Install SingleArmMRCT from local source
devtools::install_local("path/to/SingleArmMRCT")library(SingleArmMRCT)
# Closed-form solution: N = 100, Region 1 has 10 subjects (f1 = 0.1)
result <- rcp1armContinuous(
mu = 0.5,
mu0 = 0.1,
sd = 1,
Nj = c(10, 90),
PI = 0.5,
approach = "formula"
)
print(result)result <- rcp1armBinary(
p = 0.5,
p0 = 0.2,
Nj = c(10, 90),
PI = 0.5,
approach = "formula"
)
print(result)result <- rcp1armHazardRatio(
lambda = log(2) / 10,
lambda0 = log(2) / 5,
Nj = c(10, 90),
t_a = 3,
t_f = 10,
lambda_dropout = NULL,
PI = 0.5,
approach = "formula"
)
print(result)lam0 <- log(2) / 5
tstar <- 8
mu0_val <- (1 - exp(-lam0 * tstar)) / lam0
result <- rcp1armRMST(
lambda = log(2) / 10,
tau_star = tstar,
mu0 = mu0_val,
Nj = c(10, 90),
t_a = 3,
t_f = 10,
PI = 0.5,
approach = "formula"
)
print(result)Each endpoint has a corresponding plot function that generates a faceted plot of RCP as a function of the regional allocation proportion f₁, overlaying formula and simulation results for both Method 1 and Method 2.
# Continuous endpoint: RCP vs f1 for N = 20, 40, 100 with J = 3 regions
p <- plot_rcp1armContinuous(
mu = 0.5,
mu0 = 0.1,
sd = 1,
PI = 0.5,
N_vec = c(20, 40, 100),
J = 3
)
print(p)# Milestone survival endpoint
p <- plot_rcp1armMilestoneSurvival(
lambda = log(2) / 10,
t_eval = 8,
S0 = exp(-log(2) * 8 / 5),
t_a = 3,
t_f = 10,
PI = 0.5,
N_vec = c(20, 40, 100),
J = 3
)
print(p)| Symbol | Meaning | Notes |
|---|---|---|
Nj |
Integer vector of regional sample sizes | e.g., c(10, 90) for J = 2 regions |
PI |
Effect retention threshold pi | Typically ≥ 0.5; default 0.5 |
f1 |
Regional allocation proportion of Region 1 | f₁ = Nj[1] / sum(Nj) |
t_a |
Accrual period | Time-to-event endpoints only |
t_f |
Follow-up period | Time-to-event endpoints only |
lambda_dropout |
Dropout hazard rate | NULL = no dropout |
Hayashi N, Itoh Y (2017). A re-examination of Japanese sample size calculation for multi-regional clinical trial evaluating survival endpoint. Japanese Journal of Biometrics, 38(2): 79–92. https://doi.org/10.5691/jjb.38.79
Homma G (2024). Cautionary note on regional consistency evaluation in multiregional clinical trials with binary outcomes. Pharmaceutical Statistics, 23(3):385–398. https://doi.org/10.1002/pst.2358
Wu J (2015). Sample size calculation for the one-sample log-rank test. Pharmaceutical Statistics, 14(1): 26–33. https://doi.org/10.1002/pst.1654
MIT © 2025 Gosuke Homma
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.